Moderna (MRNA) Current Taxes (2021 - 2024)
Historic Current Taxes for Moderna (MRNA) over the last 4 years, with Q3 2024 value amounting to $4.0 million.
- Moderna's Current Taxes fell 9285.71% to $4.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.0 million, marking a year-over-year decrease of 9285.71%. This contributed to the annual value of $63.0 million for FY2023, which is 3125.0% up from last year.
- Moderna's Current Taxes amounted to $4.0 million in Q3 2024, which was down 9285.71% from $7.0 million recorded in Q2 2024.
- In the past 5 years, Moderna's Current Taxes ranged from a high of $1.6 billion in Q1 2022 and a low of $4.0 million during Q3 2024
- Moreover, its 4-year median value for Current Taxes was $63.0 million (2023), whereas its average is $291.6 million.
- Within the past 5 years, the most significant YoY rise in Moderna's Current Taxes was 3125.0% (2023), while the steepest drop was 9585.43% (2023).
- Quarter analysis of 4 years shows Moderna's Current Taxes stood at $876.0 million in 2021, then crashed by 94.52% to $48.0 million in 2022, then soared by 31.25% to $63.0 million in 2023, then plummeted by 93.65% to $4.0 million in 2024.
- Its last three reported values are $4.0 million in Q3 2024, $7.0 million for Q2 2024, and $52.0 million during Q1 2024.